It is not just a PR. The Melanoma PhaseII information waited for is the statistical data on the progress of the 25 patients. Final enrollment and treatment was completed on Jun 18, 2013.
Based, on the statistical response for the PhaseII OncoSec will then begin talks with the FDA to prepare for PhaseIIB Melanoma DNA-IL-12 planned for Dec 31, 2013.
LOL NON IMPACTFUL... Do you know what will be non IMPACTFUL? Your attempts to drive the PPs down, all because you want to get on the boat a little lower... Reach up and get on now--- it's leaving the dock with or without you.. Lol. Non IMPACTFUL .....